Federica Morano

21PUBLICATIONS
215CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Dec 22, 2025
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.

Paolo Manca, Marta Paoli, Francesca Galardi

|Apr 29, 2025
Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis.

Chin-Ann Johnny Ong, Joseph J Zhao, Ying Liu

|Dec 02, 2024
The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial.

Filippo Pietrantonio, Federica Morano, Monica Niger

|Aug 03, 2023
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.

Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro

|May 02, 2023
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.

Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio

|Apr 06, 2023
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer.

Carlotta Antoniotti, Alessandra Boccaccino, Robert Seitz

Pageof 4

Frequent Collaborators

16 joint publications

Filippo Pietrantonio

6 joint publications

Andrea Sartore-Bianchi

6 joint publications

Chiara Cremolini

5 joint publications

Paolo Manca